RecruitingEarly Phase 1NCT05247255
Quadratus Lumborum Block for Total Hip Arthroplasty
Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)
Sponsor
University of California, Los Angeles
Enrollment
80 participants
Start Date
Mar 29, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Adult subjects undergoing elective primary total hip arthroplasty
Exclusion Criteria5
- patients age < 18,
- documented allergy to local anesthetic
- presence of peripheral neuropathy
- patients with current long term opioid use defined as receiving an opioid on most days in a 90 day period
- patients with a contraindication to spinal and regional anesthesia such as coagulopathy or infection at the site of the regional technique.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGActive Comparator
QL block with 0.25% ropivacaine
DRUGPlacebo Comparator
QL block with saline
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05247255
Related Trials
Efficacy of Serratus Posterior Superior Intercostal Plane Block in Cardiac Device Implantation
NCT071650411 location
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
NCT041304642 locations
Dance Study for Post-surgical Pain in Breast Cancer Survivors
NCT067581021 location
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
NCT067570751 location
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
NCT069498261 location